Coulter Translational Partnership Award in Biomedical Engineering (TP)

Coulter Translational Partnership Award in Biomedical Engineering (TP)

With this Award, the Foundation formed a working partnership with the Biomedical Engineering Department to promote translational research. The Biomedical Engineering Department Chair is considered the Principle Investigator. Each school established an Oversight Committee, consisting of stake holders in the translational process. Additionally, the grant also provided funding for a Coulter Project Director to oversee the daily operations of the award. These partnerships are intended to increase the number and effective collaborations between biomedical engineers and clinicians, supporting the movement of promising technologies to clinical application, and developing sustainable processes. The Translational Research Partner Institutions worked closely with the Foundation to promote, develop and realize the clinical potential of translational research. The ultimate goal of this partnership was to focus on outcomes which save, extend, and improve patient lives suffering from any disease or condition, in any size market, in any discipline, in any country around the world.

After an extensive application and selection process during the summer of 2005, the Foundation announced in October of that year, the names of the nine Universities selected to receive the Coulter Translational Partnership Award in Biomedical Engineering in addition to the already existing program at Georgia Tech and Emory University.

Translational Partnership Phase I

Program Oversight Committee Members

  • BME Department Chair
  • Clinicians
  • Office of Technology Transfer
  • Venture Capitalists
  • Entrepreneurs
  • Industry Representatives

Translational Partnership Phase II

Based on the success of TP1, the Foundation announced the establishment of the TP2 Program. The following six universities are the recipients of the Coulter Translational Partnership Award in Biomedical Engineering: